Mucosal absorption of therapeutic peptides by harnessing the endogenous sorting of glycosphingolipids

Maria Daniela Garcia-Castillo, Daniel J.F. Chinnapen, Yvonne M. Te Welscher, Rodrigo J. Gonzalez, Samir Softic, Michele Pacheco, Randall J. Mrsny, C. Ronald Kahn, Ulrich H. von Andrian, Jesper Lau, Bradley L. Pentelute, Wayne I. Lencer

Research output: Contribution to journalArticlepeer-review

16 Citations (SciVal)

Abstract

Transport of biologically active molecules across tight epithelial barriers is a major challenge preventing therapeutic peptides from oral drug delivery. Here, we identify a set of synthetic glycosphingolipids that harness the endogenous process of intracellular lipid-sorting to enable mucosal absorption of the incretin hormone GLP-1. Peptide cargoes covalently fused to glycosphingolipids with ceramide domains containing C6:0 or smaller fatty acids were transported with 20-100-fold greater efficiency across epithelial barriers in vitro and in vivo. This was explained by structure-function of the ceramide domain in intracellular sorting and by the affinity of the glycosphingolipid species for insertion into and retention in cell membranes. In mice, GLP-1 fused to short-chain glycosphingolipids was rapidly and systemically absorbed after gastric gavage to affect glucose tolerance with serum bioavailability comparable to intraperitoneal injection of GLP-1 alone. This is unprecedented for mucosal absorption of therapeutic peptides, and defines a technology with many other clinical applications.

Original languageEnglish
Article numbere34469
Pages (from-to)1-19
Number of pages19
JournaleLife
Volume7
Early online date31 May 2018
DOIs
Publication statusPublished - 31 May 2018

Bibliographical note

© 2018, Garcia-Castillo et al.

Funding

This project was supported by a NIH F-32 DK111072-01 to MDG-C; DK084424, DK048106, DK104868, and an unrestricted innovator grant from Novo Nordisk to WIL; DK104868 to DC.; DK031036 to C RK.; HD000850 to SS.; T32 DK007477 to RJG; and PO1 AI112521 and RO1 AR068383 to Uv-A. We acknowledge the Harvard Digestive Disease Center DK034854 and the Harvard Medical School Center for Immune Imaging. We are grateful to Dr. Elisha Fielding for helping to develop animal tissue harvesting protocols and Kiara Blue for chemical synthesis of lipid-peptide fusions, as well as members of the Lencer laboratory for their helpful discussions. An innovator grant and collaboration with Novo Nordisk was awarded to WIL with no restrictions for initial studies on peptide reporter design (2012–2014). Novo Nordisk declined any and all claims to the technology in 2015.

ASJC Scopus subject areas

  • General Neuroscience
  • General Biochemistry,Genetics and Molecular Biology
  • General Immunology and Microbiology

Fingerprint

Dive into the research topics of 'Mucosal absorption of therapeutic peptides by harnessing the endogenous sorting of glycosphingolipids'. Together they form a unique fingerprint.

Cite this